Pharmaceutical Care Network Europe

The Pharmaceutical Care Network Europe (PCNE) was established in 1994 by a number of European pharmaceutical care researchers. It became an official association (under Dutch law) in 2004.

Medication Review Drug-related problem classification Guidelines and Indicators

3rd PCNE Working Conference 2003, Hillerød, Denmark

Pharmaceutical care research - the next generation

12-16 February 2003


Again, philosophy is turning into reality. This is a suitable and frequently used motto to characterise the development of pharmaceutical care over the past few years. It reflects the enthusiasm and the eftort of researchers, and the ambition of pharmacists who aim to provide the highest standard of health care.
Quality issues were the main theme of the previous working conference, in 2001, during which instrulTlents to measure outcomes in pharmaceutical care were developed. Now it is time to move on, and we would like to welcome you to join us in taking pharmaceutical care into the next generation.
The problems we are likely to confront as we take these steps are diverse, and the agenda of the Third Working Conference addresses this diversity.
The general objectives of the conference are:

  • to contribute to the development of high-quality pharmaceutical care research
  • to expand the knowledge and insights in pharmaceutical care research
  • to provide a multi-faceted view on pharmaceutical care research
  • to further the establishment of a sound methodological and scientific basis for pharmaceutical care.
  • Quality issues

Quality issues in several domains wil! be tackled: the intervention process, patient satisfaction, drug use indicators, pharmaceutical care trials, health technology assessment and outcomes, patient adherence and the economics of providing pharmaceutical care.
The experience of participants from the first two working conferences shows that this type of conference is the appropriate framework within which to stimulate research in these fields, to generate novel approaches to problem-solving and to devise new strategies. The format of this working conference uses extensive and indepth discussions among participants and workshop leaders/speakers. Posters presenting results of the work of the participants will be shown, and we will have an interactive Poster Discussion Forum.
In Hillerad, a famous town north of Copenhagen, we have a wonderful environment in which to bring together researchers and activists to share their insights and experiences. The standard of the accommodation and of the food at Pharmakon will meet the requirements of the most discerning palate, and a Leisure Centre just across the road will enable the active amongst you to keep refreshed throughout the conference. And, since meeting old friends and finding new ones -having fun -is equally important, PCNE and Pharmakon have organised a social programme that wilt improve that aspect of your quality of life.
We are certain that, if you are interested in the development of pharmaceutical care, in pharmaceutical care research and in enjoying yourself at the same time, you will enjoy being at this conference.

James McElnay, N. Ireland, Chair of the Conference

 

- Pharmaceutical Care, the way forward (Doug Hepler, USA)

- Health technology assessment in outomes research (Janine Morgall Traulsen, Denmark)

- Relationship between self-efficacy and compliance (Hanne Herborg, Denmark)

- PCNE classification of Drug-related problems (Foppe van Mil, the Netherlands)

Debate:

This house believes that high quality pharmaceutical care research cannot be carried out in community pharmacy setting (James McElnay & Foppe van Mil)

Workshop 1: Advanced study design in Pharmaceutical Care (Carmel Hughes, N. Ireland & Foppe van Mil, the Netherlands)

Workshop 2: Implementation of research findings into routine practice, including sustainability (Doug Hepler, USA & Martin Henman, Ireland)

Workshop 3: Psychosocial aspects of patient adherence (Catherine Duggan, England & Hanne Herborg, Denmark)

Workshop 4: Economic aspects of pharmaceutical care provision (Grianne Crealy, N. Ireland & Birthe Søndergaard, Denmark)

Workshop 5: Measuring outcomes - the contribution of health technology assessment (Janine Morgall Traulsen, Denmark & Martin Schulz, Germany)